Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma

Clinical trial NCT00634205 · COMPLETED

Trial details

NCT number: NCT00634205
Sponsor: European Lung Cancer Working Party
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Mesothelioma

Start date: 2006-07-01
Primary completion: 2009-03-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.